Medison integrates advanced image processing technology into ob/gyn model
Medison’s 3D Extended Imaging (3D XI) ultrasound image processing technology is now available on the SonoAce 8000 Live, its 3D ultrasound system specialized for ob/gyn, the company announced at the RSNA meeting.
Medison's 3D Extended Imaging (3D XI) ultrasound image processing technology is now available on the SonoAce 8000 Live, its 3D ultrasound system specialized for ob/gyn, the company announced at the RSNA meeting.
The technology migration makes the SonoAce 8000 Live a complete premium-performance solution, according to Medison. The midrange system provides comprehensive clinical capabilities, including 2D, 3D, and 4D.
The SonoAce 8000 Live was already distinguished by its synthetic aperture controls, volume 3D, PSAD beamformer, and sensitive power Doppler capabilities. It now provides convenient research functions, enhanced workflow efficiencies, and intuitive ergonomics as well.
Medison touts the 3D XI technology as advancing ultrasound diagnosis to a CT- or MRI-like imaging quality. It includes multislice, oblique, and volume CT view.
Multislice view transforms 3D volume data obtained from a regular ultrasound scan into a series of sequential images captured in intervals of 0.5-mm to 5-mm segments. Oblique view enables display of 3D volume data in various planes. Volume CT view enables multiple examinations of various regions and eliminates the need for multiple scanning.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
